Difference between revisions of "Ghielmini M, et al. Ann. Oncol. (2000) cited as Ref 549 in DOI: 10.1038/s41392-020-0110-5 (Q9812)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 11, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK), #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK) (English) | ||
| Property / title: The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK) (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:04, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Ghielmini M, et al. Ann. Oncol. (2000) cited as Ref 549 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Ghielmini M
0 references
Suppl. 1
0 references
2000
0 references
Ann. Oncol.
0 references
11
0 references
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK) (English)
0 references
